An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis

被引:18
作者
Skagerlind, Malin S. E. [1 ,2 ]
Stegmayr, Bernd G. [1 ]
机构
[1] Univ Umea, Dept Publ Hlth & Clin Med, Umea, Sweden
[2] Univ Hosp Umea, Ctr Med, Dept Nephrol, S-90185 Umea, Sweden
关键词
Haemodialysis; Haemorrhage; Priming; Anticoagulation; COATED POLYACRYLONITRILE MEMBRANE; REGIONAL CITRATE ANTICOAGULATION; HEPARIN-FREE DIALYSIS; SYSTEMIC ANTICOAGULATION; UNFRACTIONATED HEPARIN; HIGH-RISK; ALBUMIN; DIALYZER; NEED;
D O I
10.1007/s00228-017-2389-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to avoid clotting of the dialysis system. The aim of this study was to clarify which of four different low-dose anticoagulant modes was preferable in reducing the exposure to i.v. unfractionated heparin (heparin) and maintaining patency of the dialysis circuit. Twenty-three patients on SHD were included to perform haemodialysis with four modes of low-dose anticoagulation. For comparative analyses, patients served as their own control. Haemodialysis with a single bolus of tinzaparin at the start was compared to haemodialysis initiated without i.v. heparin but priming with (1) heparin in saline (H), (2) heparin and albumin in saline (HA), (3) heparin and albumin in combination with a citrate-containing dialysate (HAC), (4) saline and usinga heparin-coated filters (EvodialA (R)). The priming fluid was discarded before dialysis started. Blood samples were collected at 0, 30 and 180 min during haemodialysis. Smaller bolus doses of heparin (500 Units/dose) were allowed during the modes to avoid interruption by clotting. The mean activated partial thromboplastin (APTT) time as well as the doses of anticoagulation administered was highest with SHD and least with HAC and EvodialA (R). Mode H versus SHD had the highest rate of prematurely interrupted dialyses (33%, p = 0.008). The urea reduction rate was less with EvodialA (R) vs. SHD (p < 0.01). One hypersensitivity reaction occurred with EvodialA (R). Changes in blood cell concentrations and triglycerides differed between the modes. If intermittent haemodialysis is necessary in patients at risk of bleeding, anticoagulation using HAC and EvodialA (R) appeared most preferable with least administration of heparin, lowest APTT increase and lowest risk for prematurely clotted dialyzers in contrast to the least plausible H mode.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 29 条
[1]  
Antovic JP, 2010, ESSENTIAL GUIDE BLOO, P14
[2]  
Bohler J, 2004, REPLACEMENT RENAL FU, P259
[3]  
Boisseau MR, 2001, J MAL VASCUL, V26, P117
[4]   A Target-Orientated Algorithm for Regional Citrate-Calcium Anticoagulation in Extracorporeal Therapies [J].
Brandl, M. ;
Strobl, K. ;
Hartmann, J. ;
Kellner, K. ;
Posnicek, T. ;
Falkenhagen, D. .
BLOOD PURIFICATION, 2012, 33 (1-3) :7-20
[5]   Citrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: Significant clotting in the venous bubble trap [J].
Buturovic-Ponikvar, J. ;
Gubensek, J. ;
Ponikvar, R. .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (04) :323-328
[6]   The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane [J].
Chanard, Jacques ;
Lavaud, Sylvie ;
Maheut, Herve ;
Kazes, Isabelle ;
Vitry, Fabien ;
Rieu, Philippe .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (06) :2003-2009
[7]  
Criqui M H, 1997, Vasc Med, V2, P221
[8]   Unfractionated heparin or low-molecular-weight heparin in the elderly [J].
Dorobantu, Maria ;
Bogdan, Stefan .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 :1084-1090
[9]   Haemodialysis-associated anaphylactic and anaphylactoid reactions [J].
Ebo, DG ;
Bosmans, JL ;
Couttenye, MM ;
Stevens, WJ .
ALLERGY, 2006, 61 (02) :211-220
[10]   Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: A prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding [J].
Evenepoel, Pieter ;
Dejagere, Tom ;
Verhamme, Peter ;
Claes, Kathleen ;
Kuypers, Dirk ;
Bammens, Bert ;
Vanrenterghem, Yves .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (05) :642-649